The discovery of induced pluripotent stem cells (iPSCs) has created promising new avenues for therapies in regenerative medicine. However. the tumorigenic potential of undifferentiated iPSCs is a major safety concern for clinical translation. To address this issue. https://www.incredibleindiatourtravels.com/